Valuation (16%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.08 | N/A |
| PEG Ratio (TTM) | 0.00 | N/A |
| P/S Ratio (TTM) | 102.53 | N/A |
| P/B Ratio (TTM) | 0.46 | N/A |
| P/FCF Ratio (TTM) | -0.18 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -230.20% | N/A |
| ROE (TTM) | -311.33% | N/A |
| Net Profit Margin (TTM) | -41,293.77% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 19.76% | -15,076.48% | N/A |
| Revenue | -25.00% | N/A | N/A |
| Net Income | -36.29% | -15,114.60% | N/A |
| Cash Flow | -129.85% | -1,685.93% | N/A |
Health (16%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.64 | N/A |
| Quick Ratio (TTM) | 1.64 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | -1.10 | N/A |
| Piotroski F-Score | 1 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |